✦ LIBER ✦

978: A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer

✍ Scribed by Barbazan, J.; Muinelo-Romay, L.; Vieito, M.; Candamio, S.; Díaz-López, A.; Cano, A.; Gómez-Tato, A.; Casares de Cal, M.A.; Abal, M.; López-López, R.

Book ID: 125800203
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 67 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(14)50867-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multimarker panel for circulating tumo

A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer

✍ Barbazán, Jorge; Muinelo-Romay, Laura; Vieito, María; Candamio, Sonia; Díaz-Lópe 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 French ⚖ 418 KB

Circulating tumor cells as a surrogate m

Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer

✍ Satoshi Matsusaka; Mitsukuni Suenaga; Yuji Mishima; Ryoko Kuniyoshi; Koichi Taka 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Molecular profiling and predictive value

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

✍ Mitra Tewes; Bahriye Aktas; Anja Welt; Siemke Mueller; Siegfried Hauch; Rainer K 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 377 KB

753 Cytokeratin-20 as a Marker for Detec

753 Cytokeratin-20 as a Marker for Detection of Circulating Tumor Cells in Preoperative and Postoperative Blood Samples from Colorectal Cancer Patients

✍ I. Samija; J. Lukac; M. Koncar-Mubrin; I. Kirac; D. Kovacevic; Z. Kusic 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

191 DETECT III – a Multicenter, Randomiz

191 DETECT III – a Multicenter, Randomized, Phase III Study to Compare Standard Therapy Alone Versus Standard Therapy Plus Lapatinib in Patients with Initially HER2-negative Metastatic Breast Cancer and HER2-positive Circulating Tumor Cells

✍ C.A. Melcher; W. Janni; B. Rack; V. Muller; A. Schneeweiss; K. Pantel; E.F. Solo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB